Risks of the Drug Avandia (Rosiglitazone)
Links shared publicly online about this topic.
- 3,777total visits
Risks of the Drug Avandia (Rosiglitazone)
View full resource at healthline.com
Tags: Diabetes Type 2 Medication, Diabetes Medication, Drug, Avandia, Avandamet, Avandaryl
Most Recently Shared on May 23, 2007 at 7:28 am By:
New Tech Medicine post on Avandia: http://tinyurl.com/28m9oy
Drug Company to Pay $3 Billion in Damages for Diabetic Drug
articles.mercola.com — “Glaxosmithkline to pay damages for Avandia” View full resource at articles.mercola.com
Most Recently Shared on December 1, 2011 at 3:15 pm By:
Dr. Mercola Doctor, Family Medicine Doctor, and Physician
One single #drug linked to a 43% spiked heart attack risk & 64% boost in ALL cardiovascular deaths... http://t.co/99SHI0cP
Glaxo pays $3 billion to settle investigations involving alleged marketing missteps and Medicaid fraud
news-medical.net — “GlaxoSmithKline PLC said it will pay the U.S. government $3 billion to settle several long-running criminal and civil investigations into the company, including allegations that Glaxo marketed some drugs illegally and defrauded the Medicaid program. The settlement will also cover a Department of Justice probe into Glaxo's development and marketing of the diabetes drug Avandia, which has been linked to heart attack risks.” View full resource at news-medical.net
Most Recently Shared on November 4, 2011 at 7:30 am By:
Glaxo pays $3 billion to settle investigations involving alleged marketing missteps and Medicaid fraud: GlaxoSmi... http://t.co/DUzsdvqD
Medical News: EASD: 'Gliptin' Diabetes Drugs May Be Heart Savers - in Meeting Coverage, EASD from MedPage Today
medpagetoday.com — “LISBON -- While searching for potential cardiovascular risks among studies involving dipeptidyl peptidase-4 (DPP-4) inhibitors in type 2 diabetics, researchers made a surprising discovery -- treatment” View full resource at medpagetoday.com
Most Recently Shared on September 16, 2011 at 9:08 pm By:
EASD: 'Gliptin' Diabetes Drugs May Be Heart Savers (CME/CE): LISBON (MedPage Today) -- While… http://t.co/wjbooIio
New Class Of Anti-Diabetic Compound Established By Scripps Research Scientists - QualityPoint Technologies
qualitypointtech.net — “In a joint study, scientists from The Scripps Research Institute and Harvard University's Dana-Farber Cancer Institute have established a new class of anti-diabetic compound that targets a unique molecular switch. The finding paves the way for the development of anti-diabetic therapeutics with minimal adverse side effects plaguing currently available drugs such as Avandia (rosiglitazone), scheduled to be removed from pharmacy shelves this fall due to concerns about increased risk of heart attack” View full resource at qualitypointtech.net
Most Recently Shared on September 6, 2011 at 9:45 am By:
New Class Of Anti-Diabetic Compound Established By Scripps Research Scientists: In a joint study, scientists from ... http://t.co/H9HwmAg
Cardiotoxic | GreenMedInfo | Adverse Pharmacological Action | Natural Medicine | Alternative Medicine | Integrative Medicine
greenmedinfo.com — “GreenMedInfo contains 53 articles on Cardiotoxic chemicals such as Non-steroidal anti-inflammatory drugs (NSAIDs), Rosiglitazone (trade name Avandia), and Aspirin” View full resource at greenmedinfo.com
Most Recently Shared on July 27, 2011 at 7:56 pm By:
Avandia May Help Prevent Neuropathic Pain
medicalnewstoday.com — “The diabetes drug rosiglitazone (Avandia) can control inflammation leading to nerve damage and abnormal pain responses, suggests a paper in the August issue of Anesthesia & Analgesia, official jou” View full resource at medicalnewstoday.com
Most Recently Shared on July 26, 2011 at 7:05 am By:
MNT Pain News Health News and Pain Management
Avandia May Help Prevent Neuropathic Pain http://mnt.to/3Ywx #pain
Avandia May Help Prevent Neuropathic Pain
newswise.com — “Avandia May Help Prevent Neuropathic Pain” View full resource at newswise.com
Most Recently Shared on July 25, 2011 at 8:41 pm By:
#health news: Avandia May Help Prevent Neuropathic Pain: The diabetes drug rosiglitazone (Avandia) can control i... http://bit.ly/nUvlTp
Diabetes drug side effects traced to fat action
sciencedaily.com — “For better or worse, a popular class of anti-diabetic drugs does more than lower blood sugar. One known as rosiglitazone (trade name Avandia) has been in the spotlight for its possible link to increased cardiovascular events, but it also seems to come with unexplained vascular benefits and an unwelcome tendency for weight gain. Now, two separate studies explore those other effects of the drugs known collectively as thiazolidinediones (TZDs), both of which stem from their activity in fat.” View full resource at sciencedaily.com
Most Recently Shared on July 6, 2011 at 2:29 pm By:
Sara Stein MD Doctor, Psychiatrist, and Physician
#Obesity Self-defeating #Diabetes meds in class of Avandia lead to remodeling of fat cell architecture and... http://fb.me/193Pk9ygM
Side Effects Of Diabetes Drug Traced To Fat Action - Lap Band Talk Forums
lapbandtalk.com — “For better or worse, a popular class of anti-diabetic drugs does more than lower blood sugar. One known as rosiglitazone (trade name Avandia) has bee...” View full resource at lapbandtalk.com
Most Recently Shared on July 6, 2011 at 1:31 pm By:
Alex Brecher Support and ePatient
Lap Band Talk - Side Effects Of Diabetes Drug Traced To Fat Action http://bit.ly/nApaPy
Side Effects Of Diabetes Drug Traced To Fat Action
medicalnewstoday.com — “For better or worse, a popular class of anti-diabetic drugs does more than lower blood sugar. One known as rosiglitazone (trade name Avandia) has been in the spotlight for its possible link to inc” View full resource at medicalnewstoday.com
Most Recently Shared on July 6, 2011 at 9:05 am By:
Side Effects Of Diabetes Drug Traced To Fat Action http://mnt.to/3Y2k #vascular
Diabetes drug side effects traced to fat action
medicalxpress.com — “For better or worse, a popular class of anti-diabetic drugs does more than lower blood sugar. One known as rosiglitazone (trade name Avandia) has been in the spotlight for its possible link to increased cardiovascular events, but it also seems to come with unexplained vascular benefits and an unwelcome ...” View full resource at medicalxpress.com
Most Recently Shared on July 5, 2011 at 4:29 pm By:
PhysOrg Health News Health News
Diabetes drug side effects traced to fat action http://tw.medicalxpress.com/229087751
Medical News: ADA: FDA Unlikely to Zap Pioglitazone - in Meeting Coverage, ADA from MedPage Today
medpagetoday.com — “SAN DIEGO -- Bladder cancer risks aren't likely to send the diabetes drug pioglitazone (Actos) down the same path as rosiglitazone (Avandia), according to this exclusive InFocus report from the Americ” View full resource at medpagetoday.com
Most Recently Shared on June 26, 2011 at 8:54 pm By:
ADA: FDA Unlikely to Zap Pioglitazone (with video) http://bit.ly/iy2WkY
Bladder Cancer Data Prompt Labeling Update for Pioglitazone -- AAFP News Now -- American Academy of Family Physicians
aafp.org — “It was a rough spring for the class of drugs known as thiazolidinediones. Less than a month after the FDA announced it would place severe restrictions on medications containing rosiglitazone because of cardiovascular risks, the agency released new safety information June 15 linking pioglitazone to increased risks for bladder cancer.” View full resource at aafp.org
Most Recently Shared on June 23, 2011 at 11:13 am By:
Raymond DuBois Internist, Gastroenterologist, Health Executive, Physician, and Doctor
Bladder Cancer Data Prompt Labeling Update for Pioglitazone: http://t.co/wkzrOkb via @AddThis
Diabetes Drug Actos May Raise Risk for Bladder Cancer: FDA - MSN Health - Cancer
health.msn.com — “The other drug in this class Avandia is already off U.S. market due to heart risks” View full resource at health.msn.com
Most Recently Shared on June 16, 2011 at 4:31 pm By:
Diabetes Drug Actos May Raise Risk for Bladder Cancer: FDA: http://on-msn.com/mBzo2M
Diabetes Drug Actos May Raise Risk for Bladder Cancer: FDA - US News and World Report
health.usnews.com — “The other drug in this class, Avandia, is already off U.S. market due to heart risks” View full resource at health.usnews.com
Most Recently Shared on June 16, 2011 at 4:27 pm By:
Diabetes Drug Actos May Raise Risk for Bladder Cancer: FDA - US News and World Report http://fb.me/105gan6dy
Advertisement
